Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model
Standard
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. / May, Matthias; Ficarra, Vincenzo; Shariat, Shahrokh F; Zigeuner, Richard; Chromecki, Thomas; Cindolo, Luca; Burger, Maximilian; Gunia, Sven; Feciche, Bogdan; Wenzl, Valentina; Aziz, Atiqullah; Chun, Felix; Becker, Andreas; Pahernik, Sascha; Simeone, Claudio; Longo, Nicola; Zucchi, Alessandro; Antonelli, Alessandro; Mirone, Vincenzo; Stief, Christian; Novara, Giacomo; Brookman-May, Sabine; CORONA; SATURN projects; Young Acad Urologists Renal Canc G.
In: J UROLOGY, Vol. 190, No. 2, 01.08.2013, p. 458-63.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model
AU - May, Matthias
AU - Ficarra, Vincenzo
AU - Shariat, Shahrokh F
AU - Zigeuner, Richard
AU - Chromecki, Thomas
AU - Cindolo, Luca
AU - Burger, Maximilian
AU - Gunia, Sven
AU - Feciche, Bogdan
AU - Wenzl, Valentina
AU - Aziz, Atiqullah
AU - Chun, Felix
AU - Becker, Andreas
AU - Pahernik, Sascha
AU - Simeone, Claudio
AU - Longo, Nicola
AU - Zucchi, Alessandro
AU - Antonelli, Alessandro
AU - Mirone, Vincenzo
AU - Stief, Christian
AU - Novara, Giacomo
AU - Brookman-May, Sabine
AU - CORONA; SATURN projects; Young Acad Urologists Renal Canc G
N1 - Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
PY - 2013/8/1
Y1 - 2013/8/1
N2 - PURPOSE: Collecting duct renal cell carcinoma is a rare, aggressive histological subtype of renal cell carcinoma. Since few groups have evaluated the oncological prognosis in these patients based on clinical and pathological parameters, we assessed parameters prognostic for disease specific mortality.MATERIALS AND METHODS: From a cohort of 14,047 patients with renal cell carcinoma we retrieved the records of 95 with collecting duct renal cell carcinoma at a total of 16 European and American centers of the CORONA (Collaborative Research on Renal Neoplasms Association) and SATURN (Surveillance and Treatment Update Renal Neoplasms) projects, and another 2 centers. Multivariable Cox regression analysis was applied to determine the influence of parameters on disease specific mortality. Median followup was 48.1 months (IQR 24-103).RESULTS: The disease specific survival rate at 1, 2, 5 and 10 years was 60.4%, 47.3%, 40.3% and 32.8%, respectively. American Society of Anesthesiologists (ASA) score 3-4, tumor size greater than 7 cm, stage M1, Fuhrman grade 3-4 and lymphovascular invasion independently predicted disease specific mortality. Based on these parameters, patients were divided into 26 (27%) at low, 13 (14%) at intermediate and 56 (59%) at high risk with a 5-year disease specific survival rate of 96%, 62% and 8%, respectively (bootstrap corrected c-index 0.894, 95% CI 0.820-0.967, p <0.001).CONCLUSIONS: While patients with collecting duct renal cell carcinoma are commonly diagnosed at advanced stage and have poor prognosis after surgery, a subset has excellent survival. Histopathological features can help risk stratify patients based on the described, highly accurate risk model to predict disease specific mortality, facilitating patient counseling and risk based clinical decision making for adjuvant therapy and clinical trial inclusion.
AB - PURPOSE: Collecting duct renal cell carcinoma is a rare, aggressive histological subtype of renal cell carcinoma. Since few groups have evaluated the oncological prognosis in these patients based on clinical and pathological parameters, we assessed parameters prognostic for disease specific mortality.MATERIALS AND METHODS: From a cohort of 14,047 patients with renal cell carcinoma we retrieved the records of 95 with collecting duct renal cell carcinoma at a total of 16 European and American centers of the CORONA (Collaborative Research on Renal Neoplasms Association) and SATURN (Surveillance and Treatment Update Renal Neoplasms) projects, and another 2 centers. Multivariable Cox regression analysis was applied to determine the influence of parameters on disease specific mortality. Median followup was 48.1 months (IQR 24-103).RESULTS: The disease specific survival rate at 1, 2, 5 and 10 years was 60.4%, 47.3%, 40.3% and 32.8%, respectively. American Society of Anesthesiologists (ASA) score 3-4, tumor size greater than 7 cm, stage M1, Fuhrman grade 3-4 and lymphovascular invasion independently predicted disease specific mortality. Based on these parameters, patients were divided into 26 (27%) at low, 13 (14%) at intermediate and 56 (59%) at high risk with a 5-year disease specific survival rate of 96%, 62% and 8%, respectively (bootstrap corrected c-index 0.894, 95% CI 0.820-0.967, p <0.001).CONCLUSIONS: While patients with collecting duct renal cell carcinoma are commonly diagnosed at advanced stage and have poor prognosis after surgery, a subset has excellent survival. Histopathological features can help risk stratify patients based on the described, highly accurate risk model to predict disease specific mortality, facilitating patient counseling and risk based clinical decision making for adjuvant therapy and clinical trial inclusion.
KW - Adult
KW - Carcinoma, Renal Cell
KW - Female
KW - Humans
KW - Kidney Neoplasms
KW - Male
KW - Neoplasm Staging
KW - Nephrectomy
KW - Prognosis
KW - Proportional Hazards Models
KW - Regression Analysis
KW - Risk Assessment
KW - Survival Rate
U2 - 10.1016/j.juro.2013.02.035
DO - 10.1016/j.juro.2013.02.035
M3 - SCORING: Journal article
C2 - 23434943
VL - 190
SP - 458
EP - 463
JO - J UROLOGY
JF - J UROLOGY
SN - 0022-5347
IS - 2
ER -